Endothelial Cell Uptake of Infected Erythrocytes in Cerebral Malaria
脑型疟疾中感染红细胞的内皮细胞摄取
基本信息
- 批准号:9112857
- 负责人:
- 金额:$ 22.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntimalarialsApicalApoptosisBindingBlood - brain barrier anatomyBlood VesselsBrainCD36 geneCarrier ProteinsCell CommunicationCell DeathCell LineCell membraneCerebral MalariaCerebrovascular systemCerebrumClinicalComaCommunicable DiseasesDiseaseEndothelial CellsEndotheliumErythrocytesEventFunctional disorderFutureGoalsGrantHealthHumanICAM1 geneImage AnalysisIn VitroInfectionInflammationInflammatory ResponseIntercellular JunctionsLeadLeukocytesLinkMalariaMediatingMembrane ProteinsModificationMolecularNecrosisNeurologicObstructionOxygenParasitemiaParasitesPathogenesisPathologyPathway interactionsPeripheralPermeabilityPlasmodium falciparumPlayReportingRoleSignal PathwaySignal TransductionStagingSymptomsTNF geneTestingTight JunctionsTissuesUp-RegulationWorkactivated protein C receptorbrain endothelial cellburden of illnessimprovedkillingsmalaria infectionmigrationmonolayermortalitynovelperipheral blood vesselpreventreceptorsurvival outcometherapeutic developmentuptake
项目摘要
DESCRIPTION (provided by applicant): Malaria due to Plasmodium falciparum remains one of the largest global infectious disease burdens, infecting over 200 million and killing nearly 700,000 people annually. Of several possible disease manifestations, cerebral malaria has the worst survival outcomes. Cerebral malaria, characterized by coma and neurological deficits, ensues when parasitized red blood cells (pRBCs) sequester in the cerebral vasculature. Cytoadherence can contribute to disease by obstructing peripheral blood vessels, limiting oxygen delivery to tissue, and inducing significant inflammation. Cerebral pRBC sequestration is linked to breakdown of the blood brain barrier, yet the molecular mechanisms mediating vascular damage in cerebral malaria are poorly understood. The host inflammatory response plays a major role, but a more complete understanding of sequestration-related pathophysiology is necessary to develop adjunct therapies for cerebral malaria. Recent in vitro findings demonstrate that human brain endothelial cells (ECs) take up pRBCs via formation of an apical cup resembling endothelial protrusions known to mediate leukocyte transendothelial migration (TEM). ICAM1 binding in TEM activates signaling that induces cytoskeletal remodeling and junction opening to allow for migration either through or between ECs. Since pRBCs also bind ICAM1 and the cup- formation described in pRBC uptake resembles that associated with transcellular TEM, we hypothesize that pRBC cytoadherence can mistakenly induce uptake via TEM pathways and that this contributes to the pathology of cerebral malaria. Our aims seek: 1) to explore the relationship between cup formation and pRBC uptake by ECs, investigating the receptors involved and comparing different clinical isolates of P. falciparum for their ability to induce cup formation; and 2) to determine how pRBC-induced cups and uptake contribute to disruption of the EC barrier, whether this occurs by signaling pathways that open junctions or by inducing cell death. Our long term goal is to understand how pRBCs induce endothelial activation and blood brain barrier breakdown in order to improve therapeutic development. Not only is characterizing endothelial pRBC uptake in the context of leukocyte TEM pathways a novel idea, but exploring pRBC uptake has significant implications for understanding and controlling cerebral malaria pathology.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Keith Burridge其他文献
Keith Burridge的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Keith Burridge', 18)}}的其他基金
Endothelial Cell Uptake of Infected Erythrocytes in Cerebral Malaria
脑型疟疾中感染红细胞的内皮细胞摄取
- 批准号:
8969179 - 财政年份:2015
- 资助金额:
$ 22.48万 - 项目类别:
Rho-mediated Signaling in Lung Endothelial Cells Induced by Neutrophil Adhesion
中性粒细胞粘附诱导的肺内皮细胞中 Rho 介导的信号传导
- 批准号:
8321142 - 财政年份:2012
- 资助金额:
$ 22.48万 - 项目类别:
Rho-mediated Signaling in Lung Endothelial Cells Induced by Neutrophil Adhesion
中性粒细胞粘附诱导的肺内皮细胞中 Rho 介导的信号传导
- 批准号:
8473275 - 财政年份:2012
- 资助金额:
$ 22.48万 - 项目类别:
Rho-mediated Signaling in Lung Endothelial Cells Induced by Neutrophil Adhesion
中性粒细胞粘附诱导的肺内皮细胞中 Rho 介导的信号传导
- 批准号:
8651535 - 财政年份:2012
- 资助金额:
$ 22.48万 - 项目类别:
Full Project 1: LSR Alters Metabolic Signaling to Drive Aggressive Breast Cancer Behaviors
完整项目 1:LSR 改变代谢信号以驱动侵袭性乳腺癌行为
- 批准号:
10247134 - 财政年份:2010
- 资助金额:
$ 22.48万 - 项目类别:
Full Project 1: LSR Alters Metabolic Signaling to Drive Aggressive Breast Cancer Behaviors
完整项目 1:LSR 改变代谢信号以驱动侵袭性乳腺癌行为
- 批准号:
9044449 - 财政年份:2010
- 资助金额:
$ 22.48万 - 项目类别:
CB2 Cannabinoid Receptor-mediated Regulation of Prostate Cancer Growth
CB2 大麻素受体介导的前列腺癌生长调节
- 批准号:
8068504 - 财政年份:2010
- 资助金额:
$ 22.48万 - 项目类别:
Cell Adhesion and the Regulation of Rho GTPases
细胞粘附和 Rho GTP 酶的调节
- 批准号:
7999960 - 财政年份:2009
- 资助金额:
$ 22.48万 - 项目类别:
CYTOSKELETAL REGULATION OF ENDOTHELIAL CELL JUNCTIONS
内皮细胞连接的细胞骨架调节
- 批准号:
7474511 - 财政年份:2007
- 资助金额:
$ 22.48万 - 项目类别:
相似海外基金
Developing inhibitors of Plasmodium Acetyl CoA Synthetase as new multistage antimalarials
开发疟原虫乙酰辅酶A合成酶抑制剂作为新型多级抗疟药
- 批准号:
MR/X030202/1 - 财政年份:2023
- 资助金额:
$ 22.48万 - 项目类别:
Research Grant
Novel Dual-Stage Antimalarials: Machine learning prediction, validation and evolution
新型双阶段抗疟药:机器学习预测、验证和进化
- 批准号:
10742205 - 财政年份:2023
- 资助金额:
$ 22.48万 - 项目类别:
Natural Product Inspired Novel Antimalarials with Radical Cure Potential
受天然产物启发的具有根治潜力的新型抗疟药
- 批准号:
10635649 - 财政年份:2023
- 资助金额:
$ 22.48万 - 项目类别:
Novel Synergistic Antimalarials with Resistance Reversal Function
具有耐药逆转功能的新型协同抗疟药
- 批准号:
10534667 - 财政年份:2022
- 资助金额:
$ 22.48万 - 项目类别:
Plasmodium Protein Kinase Focused Antimalarials Discovery
疟原虫蛋白激酶聚焦抗疟药的发现
- 批准号:
10533634 - 财政年份:2022
- 资助金额:
$ 22.48万 - 项目类别:
Development of new lead antimalarials targeting parasite coenzyme A biosynthesis and utilisation.
开发针对寄生虫辅酶 A 生物合成和利用的新型先导抗疟药。
- 批准号:
468862 - 财政年份:2022
- 资助金额:
$ 22.48万 - 项目类别:
Operating Grants
DMPK Optimisation of B-hydroxyethylamine Antimalarials
B-羟乙胺抗疟药的 DMPK 优化
- 批准号:
2749037 - 财政年份:2022
- 资助金额:
$ 22.48万 - 项目类别:
Studentship
Repurposing antimalarials for the treatment of NTM infections
重新利用抗疟药治疗 NTM 感染
- 批准号:
10646331 - 财政年份:2022
- 资助金额:
$ 22.48万 - 项目类别:
Novel Synergistic Antimalarials with Resistance Reversal Function
具有耐药逆转功能的新型协同抗疟药
- 批准号:
10368441 - 财政年份:2022
- 资助金额:
$ 22.48万 - 项目类别:
Plasmodium Protein Kinase Focused Antimalarials Discovery
疟原虫蛋白激酶聚焦抗疟药的发现
- 批准号:
10663334 - 财政年份:2022
- 资助金额:
$ 22.48万 - 项目类别: